The Notch receptor mediates cell fate decision in multiple organs. In the current work we tested the hypothesis that Nkx2.5 is a target gene of Notch1 and raised the possibility that Notch1 regulates myocyte commitment in the adult heart. Cardiac progenitor cells (CPCs) in the niches express Notch1 receptor, and the supporting cells exhibit the Notch ligand Jagged1. The nuclear translocation of Notch1 intracellular domain (N1ICD) up-regulates Nkx2.5 in CPCs and promotes the formation of cycling myocytes in vitro. N1ICD and RBP-Jk form a protein complex, which in turn binds to the Nkx2.5 promoter initiating transcription and myocyte differentiation. In contrast, transcription factors of vascular cells are down-regulated by Jagged1 activation...
Numb family proteins (NFPs), including Numb and Numblike (Numbl), are commonly known for their role ...
During vertebrate cardiac development NOTCH signaling activity in the endocardium is essential for t...
Background: Progenitor cell therapy is emerging as a novel treatment for heart failure. However the ...
Development of the vertebrate heart is a complex process involving the interaction of multiple diffe...
The identification of the molecular mechanisms controlling cardiomyocyte proliferation during the em...
Background—The signaling mechanisms that regulate the recruitment of bone marrow (BM)–derived cells ...
Rationale: Physiological hypertrophy in the developing heart has been considered the product of an i...
In metazoans, the Notch pathway is one of the crucial pathways that regulate cell fates and tissue f...
In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. The recent d...
In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. The recent d...
Rebuilding the human myocardium following pathological injury remains a significant challenge both a...
Embryonic stem cells represent an attractive source of cardiomyocytes for cell-replacement therapies...
Grego-Bessa, Joaquín et al.Ventricular chamber morphogenesis, first manifested by trabeculae formati...
Regulation of multipotent cardiac progenitor cell (CPC) expansion and subsequent differentiation int...
To efficiently generate cardiomyocytes from embryonic stem (ES) cells in culture it is essential to ...
Numb family proteins (NFPs), including Numb and Numblike (Numbl), are commonly known for their role ...
During vertebrate cardiac development NOTCH signaling activity in the endocardium is essential for t...
Background: Progenitor cell therapy is emerging as a novel treatment for heart failure. However the ...
Development of the vertebrate heart is a complex process involving the interaction of multiple diffe...
The identification of the molecular mechanisms controlling cardiomyocyte proliferation during the em...
Background—The signaling mechanisms that regulate the recruitment of bone marrow (BM)–derived cells ...
Rationale: Physiological hypertrophy in the developing heart has been considered the product of an i...
In metazoans, the Notch pathway is one of the crucial pathways that regulate cell fates and tissue f...
In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. The recent d...
In the damaged heart, cardiac adaptation relies primarily on cardiomyocyte hypertrophy. The recent d...
Rebuilding the human myocardium following pathological injury remains a significant challenge both a...
Embryonic stem cells represent an attractive source of cardiomyocytes for cell-replacement therapies...
Grego-Bessa, Joaquín et al.Ventricular chamber morphogenesis, first manifested by trabeculae formati...
Regulation of multipotent cardiac progenitor cell (CPC) expansion and subsequent differentiation int...
To efficiently generate cardiomyocytes from embryonic stem (ES) cells in culture it is essential to ...
Numb family proteins (NFPs), including Numb and Numblike (Numbl), are commonly known for their role ...
During vertebrate cardiac development NOTCH signaling activity in the endocardium is essential for t...
Background: Progenitor cell therapy is emerging as a novel treatment for heart failure. However the ...